Gene Directed Enzyme Prodrug Therapy (GDEPT)
Section: Section of Cell and Molecular Biology including the Cancer Research UK Tumour Cell Signalling Unit
Gene Directed Enzyme Prodrug Therapy
Investigators: P Lehouritis, S Schepelman, S Walker; in collaboration with C Springer, Cancer Research UK Centre for Cancer Therapeutics
Our work on using adenoviruses to deliver the bacterial enzyme, carboxypeptidase G2 to tumour cells has continued, and this work will be reported in detail by Professor Caroline Springer (see project reports for the Gene and Oncogene Targeting Team).
The funding of this project is external.
In the Section of Cell and Molecular Biology including the Cancer Research UK Tumour Cell Signalling Unit
